Federated Hermes
OXFD

Federated Hermes’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Federated Hermes’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-118
Closed -$2K – 2332
2019
Q2 		$2K Buy
+118
New +$1.8K ﹤0.01% 2092
2019
Q1 		– Sell
-347
Closed -$4K – 2263
2018
Q4 		$4K Buy
+347
New +$5.26K ﹤0.01% 2027

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Federated Hermes's OXFD Position: Q3 2019 in Review

Federated Hermes sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 118 shares — an estimated $2K sold.

Federated Hermes first reported a position in OXFD in Q4 2018 and held it in 2 quarters. The position peaked at $4K in Q4 2018. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

  • Federated Hermes reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • Federated Hermes sold 118 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $2K.
  • Federated Hermes first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2018 and held it in 2 quarters.
  • Federated Hermes's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4K in Q4 2018.
  • 73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.